| MEDIWOUND LTD IS-,01 |
| Israel |
| Gesundheit |
| IL0011316309 / A110TG |
| M8W (Frankfurt) / MDWD (NASDAQ) |
| FRA:M8W, ETR:M8W, M8W:GR, NASDAQ:MDWD |
| - |
| https://mediwound.com/ |
|
MediWound Ltd. is an integrated biopharmaceutical company specializing in next-generation enzymatic therapeutics for non-surgical tissue repair. The company develops, manufactures, and commercializes biologics that address unmet needs in severe burns..
>Volltext.. |
| 181.73 Mio. EUR |
| 144.4 Mio. EUR |
| 14.52 Mio. EUR |
| -20.06 Mio. EUR |
| -20.45 Mio. EUR |
| -1.8 EUR |
| 7.51 Mio. EUR |
| 4.11 Mio. EUR |
| -12.83 Mio. EUR |
| 2.07 |
| -26.08% |
| 30.36% |
| - |
| - |
| - |
| - |
| MEDIWOUND |
| 08.04.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|